Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 on the page footer, indicating a software release; no study details or results appear to be altered.SummaryDifference0.0%

- Check12 days agoChange DetectedA funding attribution line indicating a 2019 U.S. NIH grant/contract was added. This addition provides funding source context but does not alter study details or eligibility.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision tag was updated to v3.6.5, replacing the previous v3.6.4, reflecting a minor update to the page version.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now shows Revision: v3.6.4 in the site metadata, replacing the previous v3.6.3. This change reflects a software release and does not alter study information or data.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor maintenance update to the page with no substantive content changes.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page displays an updated revision tag, changing from v3.6.0 to v3.6.2, indicating an update to the page version. This update signals an internal refinement of the page rather than a change to the study content.SummaryDifference0.0%

Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.